A recent study of 80 overweight adults participating in a 24-month treatment program concluded that gastric surgery with a LapBand® system to be significantly more effective than
nonsurgical therapy in reducing weight, resolving the metabolic syndrome, and improving quality of life.
Published in the Annals of Internal Medicine by Drs. Paul E. O'sBrien and John B. Dixon (Monash University and University of Melbourne, Australia), the objective of the study was to
ascertain in a randomized, controlled trial whether surgery was more effective than dieting for individuals who would not normally weigh enough to be considered candidates for weight loss
surgery.
Taking 80 adults with mild to moderate obesity (BMI 30-35 kg/m2) from the general community, the study split them into two groups. The nonsurgical therapy group participated in a program
of very-low-calorie diets, pharmacotherapy, and lifestyle changes for 24 months, while the surgical group were assigned placement of a laparoscopic adjustable gastric band, or LapBand®
system.
At two years, the surgical group demonstrated greater weight loss, with a mean of 21.6% of initial weight lost, and 87.2% of excess weight lost, while the nonsurgical group showed a mean
of only 5.5% and 21.8%, respectively. Other statistics revealed the metabolic syndrome was initially present in 15 (38%) patients in each group and was present in 1 (3%) surgical patient
and 8 (24%) nonsurgical patients at the completion of the study. Quality of life improved statistically significantly more in the surgical group (8 of 8 subscores of Short Form-36) than
in the nonsurgical group.
Asked to comment on the study, Dr. Gregg Jossart, of Laparoscopic Associates of San Francisco, stated, 's8220;it is significant to see the long-term benefits of bariatric procedures like
the LapBand® system, duodenal switch, vertical gastrectomy, and Roux en Y gastric bypass. The study underscores the growing opinion in the medical community that LapBand® and other
bariatric surgeries are an effective solution for reducing excess weight and improving quality of life's8221;. Dr. Paul Cirangle, a laparoscopic surgeon who practices in the Sacramento,
San Francisco and San Jose areas, also commented that the vertical gastrectomy procedure, as demonstrated in the study, is an excellent option for individuals with a BMI between 30 and 35
Kg/M2.
The study was the first randomized trial of contemporary surgical methods, with the editors noting that laparoscopic gastric banding (LapBand®) is an effective treatment for mild to
moderate obesity, reducing weight, resolving the metabolic syndrome, and improving the quality of the patient's8217;s life during a 24-month program.
About Laparoscopic Associates of San Francisco www.lapsf.com
Based in the San Francisco Bay Area, Laparoscopic Associates performs all weight-loss surgeries laparoscopically, including http://www.lapsf.com/lapband-weight-loss-surgery.php[LapBand®, http://www.lapsf.com/roux-en-y-gastric-bypass-weight-loss-surgery.php[Roux en Y gastric bypass, http://www.lapsf.com/duodenal-switch-weight-loss-surgery.php[duodenal switch and vertical gastrectomy. They also feature a total care support system including Obesity
Surgery Seminars, a Patient Support Group, a Chat Room, and a complete resource directory for your obesity help.
More information about weight-loss surgery can be found on LAPSF's8217;s Website, www.lapsf.com, or by contacting Laparoscopic Associates of San
Francisco, 2100 Webster Street, Suite 518, San Francisco, CA 94115, phone: 415-561-1310, fax: 415-561-1731.